Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003645 |
---|---|
Receipt number | R000004410 |
Scientific Title | Phase II study of CDDP/Alimuta combined with bevacizumab in patients with advanced non-small-cell lung cancer without harboring sensitive EGFR mutations |
Date of disclosure of the study information | 2011/01/01 |
Last modified on | 2020/05/27 10:51:00 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/05/20 17:40:23 | ||
2 | Update | 2013/05/20 09:22:44 | Institute Institute Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2016/05/20 19:15:42 | Recruitment status |
|
4 | Update | 2020/05/27 10:51:00 | Recruitment status Date of IRB |